With the exception of minimal expression of CD80 in TF-1 cells, these two human AML cell lines lacked expression of the inhibitory T-cell ligands, PD-L1, PD-L2 or the activating T-cell ligands, CD80, CD86. Here, CD86 is linked to acute myeloid leukemia.